Interaction studies of Angelica polymorpha and Beilschmiedia pulverulenta phytochemicals with acetylcholinesterase as anti-Alzheimer's disease target
by Tomisin Happy Ogunwa
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 12, No. 1, 2019

Abstract: Angelica polymorpha and Beilschmiedia pulverulenta are medicinal plants locally used by people in some parts of Asia and Africa due to their beneficial health effects particularly in the treatment of Alzheimer's disease (AD). The phytoconstituents responsible for such bioactivity have recently been identified in the plants. Herein, in silico approach was used to explore the interaction of such phytochemicals with acetylcholinesterase (AChE) as a validated target in the treatment of AD to provide insights into their precise binding pattern and affinity, order of chemical interaction, inhibitory potential and residues that contribute to the enzyme-phytoconstituent complex stability. With binding affinity ranging from -7.0 kcal/mol to -10.2 kcal/mol and tacrine-comparable orientation, the chemical scaffold of the phytochemicals from both plants displayed deep penetration and fit conveniently into the narrow gorge of AChE. Optimisation of these ligands scaffold might yield new AChE inhibitors with desirable higher efficacy.

Online publication date: Tue, 05-Mar-2019

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email